Renaissance Capital logo

Elevai Labs Priced, Nasdaq: ELAB

Makes physician-dispensed skincare products.

Industry: Consumer Staples

Latest Trade: $2.23 0.00 (0.0%)

First Day Return: -15.0%

Return from IPO: -99.7%

Industry: Consumer Staples

We are a physician-dispensed skincare company with a focus on modernizing aesthetic skincare. We conduct research and development to advance innovative and science-driven topical skincare that complements the medical aesthetics industry. Upon our founding in 2020, we initiated our research and development phase for our current product formulations. Since 2022, we have principally employed a business-to-business model in which we produce and commercialize a new generation of topical skincare products that contain our proprietary stem cell-derived Elevai ExosomesTM designed to enhance the appearance of skin. Our exosome manufacturing process from source to skin is known as ‘Precision Regenerative Exosome Technology™’ or ‘PREx™’. PREx™ utilizes advanced patent-pending stem cell processing technology as part of our cohesive production process involving carefully controlled stem cell culture to produce stem cell derived factors that are featured in our topical exosome products. Specifically, as referenced herein “exosomes” are small membrane-bound vesicles that are released by cells that are involved in intercellular communication. They contain various types of biomolecules such as proteins, lipids, and nucleic acids, which can be transferred between cells and may modulate and support these natural cellular processes.
more less
IPO Data
IPO File Date 09/29/2023
Offer Price $4.00
Price Range $4.00 - $6.00
Offer Shares (mm) 1.5
Deal Size ($mm) $6
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 11/20/2023
Offer Price $4.00
Price Range $4.00 - $6.00
Offer Shares (mm) 1.5
Deal Size ($mm) $6
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Univest Securities
Webull Financial
Company Data
Headquarters Newport Beach, CA, United States
Founded 2020
Employees at IPO 16
Website elevailabs.com

Elevai Labs (ELAB) Performance